Product Information
POTASSIUM CL ER 10 MEQ TABLET is a generic product labeled by Actavis Pharma, Inc., priced at $0.1349 per EA under NDC 62037071001. Its NADAC has been published 658 times since Nov 28, 2013.
FDA first approved this application on Apr 10, 2002. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 meq/1
Manufacturer
Actavis Pharma, Inc.NDC
62037071001
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
POTASSIUM CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA075604FDA Approved
4/10/2002
TE Code
AB1
On Market Since
4/10/2002
Pharmacological Classes
Price Statistics
The NADAC for POTASSIUM CL ER 10 MEQ TABLET has been published 658 times since Nov 28, 2013, and over the history we have for it it has declined 55.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1349 per EA |
|---|---|
| All-time high | $0.3229 (Jan 15, 2014) |
| All-time low | $0.0902 (Jul 17, 2024) |
| 52-week high | $0.1380 |
| 52-week low | $0.1186 |
| Median price | $0.2515 |
| Average price | $0.2240 |
| Largest weekly change | +61.7% (Jun 19, 2024) |
| Weeks tracked | 658 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
-2.3%
6M
+1.4%
1Y
+2.9%
3Y
-16.2%
5Y
-46.6%
All
-55.1%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of POTASSIUM CL ER 10 MEQ TABLET?
The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CL ER 10 MEQ TABLET, manufactured by Actavis Pharma, Inc., is $0.1349 per EA (NDC 62037071001), effective Jul 1, 2026.
How has the price of POTASSIUM CL ER 10 MEQ TABLET changed over time?
Over the history we have for it, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has declined 55.1%. It has been tracked across 658 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for POTASSIUM CL ER 10 MEQ TABLET?
Since Nov 28, 2013, the NADAC for POTASSIUM CL ER 10 MEQ TABLET has ranged from a low of $0.0902 (Jul 17, 2024) to a high of $0.3229 (Jan 15, 2014), with a median of $0.2515 per EA.
Are there cheaper alternatives to POTASSIUM CL ER 10 MEQ TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, POTASSIUM CL ER 10 MEQ TABLET, is $0.0902 per EA — about 33% below POTASSIUM CL ER 10 MEQ TABLET.
Who manufactures POTASSIUM CL ER 10 MEQ TABLET?
POTASSIUM CL ER 10 MEQ TABLET (NDC 62037071001) is labeled by Actavis Pharma, Inc., and CMS classifies it as a generic product.